ASTH
Price
$40.81
Change
+$3.02 (+7.99%)
Updated
Aug 14 closing price
Capitalization
2.02B
82 days until earnings call
Intraday BUY SELL Signals
DVA
Price
$180.06
Change
+$0.89 (+0.50%)
Updated
Aug 14 closing price
Capitalization
11.49B
69 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ASTH vs DVA

ASTH vs DVA Comparison Chart in %
View a ticker or compare two or three
VS
ASTH vs. DVA commentary
Aug 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a StrongBuy and DVA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 15, 2026
Stock price -- (ASTH: $40.81 vs. DVA: $180.06)
Brand notoriety: ASTH: Not notable vs. DVA: Notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: ASTH: 57% vs. DVA: 55%
Market capitalization -- ASTH: $2.02B vs. DVA: $11.49B
ASTH [@Hospital/Nursing Management] is valued at $2.02B. DVA’s [@Hospital/Nursing Management] market capitalization is $11.49B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $87.61B to $0. The average market capitalization across the [@Hospital/Nursing Management] industry is $4.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASTH’s FA Score shows that 0 FA rating(s) are green whileDVA’s FA Score has 1 green FA rating(s).

  • ASTH’s FA Score: 0 green, 5 red.
  • DVA’s FA Score: 1 green, 4 red.
According to our system of comparison, DVA is a better buy in the long-term than ASTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASTH’s TA Score shows that 4 TA indicator(s) are bullish while DVA’s TA Score has 5 bullish TA indicator(s).

  • ASTH’s TA Score: 4 bullish, 6 bearish.
  • DVA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DVA is a better buy in the short-term than ASTH.

Price Growth

ASTH (@Hospital/Nursing Management) experienced а +14.12% price change this week, while DVA (@Hospital/Nursing Management) price change was -2.02% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -0.41%. For the same industry, the average monthly price growth was +0.47%, and the average quarterly price growth was +47.32%.

Reported Earning Dates

ASTH is expected to report earnings on Nov 05, 2026.

DVA is expected to report earnings on Oct 23, 2026.

Industries' Descriptions

@Hospital/Nursing Management (-0.41% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DVA($11.5B) has a higher market cap than ASTH($2.02B). ASTH has higher P/E ratio than DVA: ASTH (49.76) vs DVA (15.26). ASTH YTD gains are higher at: 64.490 vs. DVA (58.490). DVA has higher annual earnings (EBITDA): 2.71B vs. ASTH (163M). DVA has more cash in the bank: 667M vs. ASTH (478M). ASTH has less debt than DVA: ASTH (1.07B) vs DVA (13.2B). DVA has higher revenues than ASTH: DVA (13.8B) vs ASTH (3.53B).
ASTHDVAASTH / DVA
Capitalization2.02B11.5B18%
EBITDA163M2.71B6%
Gain YTD64.49058.490110%
P/E Ratio49.7615.26326%
Revenue3.53B13.8B26%
Total Cash478M667M72%
Total Debt1.07B13.2B8%
FUNDAMENTALS RATINGS
ASTH vs DVA: Fundamental Ratings
ASTH
DVA
OUTLOOK RATING
1..100
5662
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
80
Overvalued
PROFIT vs RISK RATING
1..100
10056
SMR RATING
1..100
874
PRICE GROWTH RATING
1..100
4660
P/E GROWTH RATING
1..100
6434
SEASONALITY SCORE
1..100
4150

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ASTH's Valuation (75) in the null industry is in the same range as DVA (80) in the Medical Or Nursing Services industry. This means that ASTH’s stock grew similarly to DVA’s over the last 12 months.

DVA's Profit vs Risk Rating (56) in the Medical Or Nursing Services industry is somewhat better than the same rating for ASTH (100) in the null industry. This means that DVA’s stock grew somewhat faster than ASTH’s over the last 12 months.

DVA's SMR Rating (4) in the Medical Or Nursing Services industry is significantly better than the same rating for ASTH (87) in the null industry. This means that DVA’s stock grew significantly faster than ASTH’s over the last 12 months.

ASTH's Price Growth Rating (46) in the null industry is in the same range as DVA (60) in the Medical Or Nursing Services industry. This means that ASTH’s stock grew similarly to DVA’s over the last 12 months.

DVA's P/E Growth Rating (34) in the Medical Or Nursing Services industry is in the same range as ASTH (64) in the null industry. This means that DVA’s stock grew similarly to ASTH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASTHDVA
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
65%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 18 days ago
67%
Declines
ODDS (%)
Bearish Trend 18 days ago
76%
Bearish Trend 5 days ago
57%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
58%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
ASTH
Daily Signal:
Gain/Loss:
DVA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IAE8.840.09
+1.03%
VOYA ASIA PACIFIC HIGH DIVIDEND EQUITY Income FUND
WTIP36.190.01
+0.03%
WisdomTree Inflation Plus Fund
HYDB46.50-0.03
-0.06%
iShares High Yield Systematic Bond ETF
YBIT17.97-0.07
-0.39%
Yieldmax Bitcoin Option Income Strategy ETF
BITU9.00-0.14
-1.53%
ProShares Ultra Bitcoin ETF

ASTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with SGRY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then SGRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASTH
1D Price
Change %
ASTH100%
+7.99%
SGRY - ASTH
36%
Loosely correlated
-1.05%
HCA - ASTH
30%
Poorly correlated
-1.71%
ACHC - ASTH
30%
Poorly correlated
+1.95%
NHC - ASTH
28%
Poorly correlated
+1.71%
HCSG - ASTH
27%
Poorly correlated
+2.37%
More